Oscar Health Inc is trading 4.9% up now at $24.75 as investors extend the sharp move that followed Wells Fargo’s June 4 upgrade and price-target hike.
- The stock continues to benefit from a bullish post-earnings narrative centered on improving profitability and reaffirmed 2026 guidance.
- Recent analyst price targets in the high-teens to low-$20s range have bolstered investor sentiment, despite a weaker overall market backdrop.